January 09, 2023

Prepare for the 2023 ISN Leadership Elections: Meet the Candidates and Renew Your Membership to Vote - a Message From the ISN Nominating Committee Chair
Your vote counts! Jürgen Floege, chair of the ISN Nominating Committee, encourages all to help shape the ISN’s future by choosing the best candidates to lead the ISN - voting opens January 23.
ISN Fellow Returns Home to Start Interventional Nephrology Programs in Pondicherry, India
Find out how Venkatram Murugesan will address kidney care gaps in his hometown after six-months of training through the ISN Fellowship Program.
The ISN Welcomes a New Collective-Member Society
The UK Kidney Association has joined the ISN as a Collective-Member Society.
 ISN News 
Thank You for Your Support in 2022. The ISN Membership Year Began January 1: Renew or Join Now for Maximum Benefits
Early Bird Registration Ends January 18 - Register Now and Save up to $100!
“The Story Is More Important Than the Technical Aspect” - Share Your Story of Unsung Heroes in Kidney Care: Submit a Film to the ISN Community Film Event
Meet the 2023 ISN WCN Social Media Team
Apply to the ISN Clinical Research Program (CRP) - Get Help With Your Application From ISN CRP Chairs at 9 a.m. CET on January 10
Give Professional Guidance and Develop Leadership and Communication Skills - Apply by March 1 to Become an ISN Mentor
International Practices and Challenges Surrounding COVID-19 Vaccination - Results From ISN Survey Published in BMJ Open
ISN i3C Working Group Meeting on Intervention Strategies for Chronic Kidney Disease of Unknown Origin Generates Publication
Explore the ISN Global Trials Focus Selection for December Featuring ‘Trial of the Month’ on Personalized Cooler Dialysate for Patients Receiving Maintenance Hemodialysis
Catch Up on Recent and Upcoming DICG Activities in the Latest Edition of Their Newsletter
“Hypertensive Disorders in Pregnancy” and “Pregnancy Associated Acute Kidney Injury”: Watch and Share Two New Modules in the Open-access Online Kidney Education for Primary Care Physicians Curriculum
Tuesday, January 10  I  9 a.m. CET
ISN Webinar:
How to Apply for the Clinical Research Program: Tips and Tricks From the Program Chairs on What Makes for a Successful Application
Thursday, January 12  I  2 p.m. CET
Grand Rounds in Pediatric Nephrology - an ISN-IPNA Sister Centers Initiative:
Renal Amyloidosis Presenting as Glucocorticoid Resistant Nephrotic Syndrome
Tuesday, January 17  I  12 p.m. (noon) CET
ISN Webinar:
Mixed Methods Research in Kidney Care
Join or renew your membership here to access these webinars
ISN Latin America Regional Board - SLANH Webinar:
Desarrollo del Área de Nefrología Intervencionista: El Reto de Lograr un Programa Internacional de Intervencionismo Renal con Práctica y Formación de Fellows
(in Spanish)
GlomCon-ISN Webinar:
Secondary IgA Nephropathy - Reality or Illusion?
ISN Middle East Regional Board Webinar:
Hypertension in the Middle East Region
ISN Webinar:
Encore Presentation of EMPA-KIDNEY Trial Data  
Access the Latest ISN Journal Articles on Covid-19
Discover the Latest Video Abstracts
Watch the latest ISN video abstracts from the @ISNeducation Social Media Team.
Watch the videos here.
The videos are based on papers from Kidney International and Kidney International Reports:
Incidence of New Onset Glomerulonephritis After SARS-CoV-2 mRNA Vaccination Is Not Increased
Persistent Isolated C3 Hypocomplementemia as a Strong Predictor of End-stage Kidney Disease in Lupus Nephritis
Defining Measures of Kidney Function In Observational Studies Using Routine Health Care Data: Methodological and Reporting Considerations
This review illustrates the diversity of working definitions of kidney disease in scientific literature and discusses the advantages and limitations of the most commonly used approaches.
The authors summarize ways to identify and overcome possible biases and propose a framework for reporting definitions of exposures and outcomes in studies of kidney disease using routinely collected health care data.
Novel Treatment Paradigms: Focal Segmental Glomerulosclerosis
Recent advances in defining the genetic and immunologic basis of disease have redefined the classification of focal segmental glomerulosclerosis (FSGS).
New clinical trial activity and the successful use of repurposed agents offer hope for improved treatments.
This mini-review summarizes these advances with a focus on novel treatment paradigms.